Improves the effectiveness of many other anticonvulsants and is indicated as an adjunctive therapy with sodium valproate and clobazam for treating severe myoclonic epilepsy in infancy (SMEI, also know as Dravet syndrome). Possible side effects: Nausea and vomiting are particularly noted when used in combination with sodium valproate.